To our knowledge, this is the first study to suggest a higher prevalence of thyroid hormone supplementation in patients with pancreatic cancer and to demonstrate the proliferative effects of T3 in pancreatic cancer cell lines. This evidence concerns the gene TG and pancreatic neoplasm.